A Nutanix study reveals GenAI is changing organisations' priorities, with security and privacy being a primary concern.

In the closing of the recent trading day, Nutanix (NTNX) stood at $70.28, denoting a -1.83% change from the preceding trading day.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Nutanix improves financials with robust strategies against VMware, offering cost efficiencies. Strong margins ahead, but high ...

Nutanix offers healthcare organizations a streamlined, scalable path to adopting GenAI technologies with Nutanix Enterprise ...

Rajiv Ramaswami, the President and CEO of Nutanix, Inc. (NASDAQ:NTNX), has sold 95,852 shares of the company's Class A common ...

SAN JOSE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Nutanix, Inc. (NASDAQ: NTNX), a leader in hybrid multicloud computing, today announced that it will report its financial results for the second ...

Multiple backup products found carrying a critical severity flaw allowing malicious actors to run arbitrary commands on ...

A Treasury official says DOGE team members have “read-only” access to the data from its payment systems as part of an “operational efficiency assessment." ...